Catalogue Number: 18135-IBL
|Manufacturer:||IBL - (Immuno-Biologicals Laboratories Co Ltd)|
|Physical state:||Lyophilized product from 1 % BSA in PBS containing 0.05% NaN3|
|Type:||Polyclonal Primary Antibody - Unconjugated|
|Shipping Condition:||Blue Ice|
|Unit(s):||100 ug, 10 ug|
|Immunogen:||Synthetic peptide of the C-Terminal part of Human HGFα(SCAKTKQLR)|
Description: Hepatocyte Growth factor (HGF) was discovered as a mitogen for hepatocytes. HGF was subsequently found to be identical to the scatter factor, which destroys epithelial cell adhesion and promotes cell movement. Some reports have Hepatocyte Growth factor (HGF) was discovered as a mitogen for hepatocytes. HGF was subsequently found to be identical to the scatter factor, which destroys epithelial cell adhesion and promotes cell movement. Some reports have shown that HGF is expressed in normal and malignant mammary epithelium. HGF has also been reported to promote motility and growth of epithelial cells, to induce morphogenesis of epithelial cells and to promote vascularization. It has been speculated that HGF is involved in the growth and metastasis of cancer cells. The first step in the initiation of HGF action is dependent on its biding to a specific cell surface receptor, the HGF receptor, encoded by the proto-oncogene c-Met. It has been suggested that c-Met mediates both responses, i.e., promotion of growth and motility of HGF. HGF is synthesized as a 728 amino acid that is processed to generate the mature growth factor consisting of a disulfide-linked 69 kDa α 34 kDa β chain.
Cross-reacts with Rat HGFα. Not-cross react with Human HGFβ.